Quest Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Quest Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$242K	Buy	+3,878	New	+$227K	0.04%	277

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quest Capital Management's BMY Position: Q4 2021 in Review

Quest Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2021: 3,878 shares worth $242K. The stake represents 0.04% of the portfolio and ranks #277 among its holdings.

2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Quest Capital Management held 3,878 shares of Bristol-Myers Squibb worth $242K as of Q4 2021.
Bristol-Myers Squibb was a new Quest Capital Management position in Q4 2021.
Bristol-Myers Squibb made up 0.04% of Quest Capital Management's portfolio in Q4 2021, its #277 holding.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.